Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

By Mariam Sunny and Bhanvi Satija (Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on ...

Operator Hello, and welcome to the Kenvue third quarter 2024 earnings conference call. All lines have been placed on mute to ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...

Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in ...

Fiera Capital Corp reduced its position in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 9.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...

Kenvue, Inc. ( (KVUE)) has released its Q3 earnings. Here is a breakdown of the information Kenvue, Inc. presented to its investors. Kenvue, Inc., the world’s largest pure-play consumer health company ...

Reports Q3 revenue $3.9B, consensus $3.93B. “During the third quarter, we continued to drive strong productivity and realize efficiency ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...